Mandate

Vinge advises Swedbank in connection with share issues in Brinova Fastigheter

December 15, 2016

Vinge advises Swedbank AB (publ) in connection with two share issues in Brinova Fastigheter AB (publ), both a rights issue of shares of class B amounting to approximately SEK 210 million, as well as a share issue of shares of class B to the general public, amounting to approximately SEK 48 million, with deviation from the shareholders pre-emption rights. A prospectus was published on 29 November 2016. Brinova Fastigheter is listed on Nasdaq First North Premier.

Vinge’s team consists of Jesper Schönbeck and Nils Fredrik Dehlin.

Related

Vinge advises Blackstone in connection with its investment in Winthrop Technologies

Vinge, as local Swedish counsel, advised Blackstone Tactical Opportunities and affiliated funds (“Blackstone”) in connection with a strategic partnership with Winthrop Technologies Limited (“Winthrop Technologies”).
April 17, 2024

Vinge has advised Hansa Biopharma in connection with a directed share issue of SEK 372 million

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of SEK 372 million before transaction costs. Hansa Biopharma is a commercial-stage biopharmaceutical company pioneering the development and commercialization of innovative, lifesaving and life altering treatments for patients with rare immunological conditions. Hansa Biopharma’s ordinary share is listed on Nasdaq Stockholm.
April 16, 2024

Vinge advises Triton in connection with the divestment of Norstat to Nalka Invest

Vinge advises Triton Smaller Mid-Cap Fund I (“Triton”) in connection with the divestment of Norstat, a leading data collector for market research, to Nalka Invest.
April 12, 2024